Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  8, Issue 1, Jan-Feb 2019, Pages 106-109
 

Original Article

Correlative Study of Ki67 with Other Molecular Markers in Breast Cancer in South Karnataka Population of India

Nanjundaswamy Doddaiah

Assistant Professor, Department of Pathology, Adichunchanagiri Institute of Medical Sciences (AIMS), B.G. Nagara, Mandya Dist., Karnataka 571448, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.8119.16

Abstract

 40 females aged between 25 to 65 years old having breast cancer were studied during 2016 and August 2018. 15 (37.5%) were tobacco chewers, 4 (10%) were smokers 3 (7.5%) were alcoholic and 18 (45%) were mal-nutritious. Expression of ki67 and its histopathological correlation was found to be 4(10%) patients had IDC grade I malignancy, 22 (55%) had IDC grade II malignancy, 14 (35%) had IDC grade – III malignancy, 5 (12.5%) axillary lymph nodes had negative expression, while 35 (87.5%) expressed positivity for ki67 bio marker. The size of tumour were 4 (10%) were <2 cm and 36 (90%) with > 2 cm in the correlative study of ki67 with PR score value was 0.58, with ER score value was 0.18 and with HER-2/ neu value was 1.0 and all three correlation were statistically insignificant. This study confirmed that increasein ki67 – positivity has poorer prognosis hence ki67 biomarker plays significant role inthe prognostic value in breast cancer

Keywords: Er = Estrogen Receptor; Pr = Progesterone Receptor; Her-2 = Human Epidermal Growth Factor Receptor -2.


Corresponding Author : Nanjundaswamy Doddaiah,